Atomo Diagnostics Limited (ASX:AT1)
Australia flag Australia · Delayed Price · Currency is AUD
0.0400
-0.0020 (-4.76%)
At close: Feb 5, 2026

Atomo Diagnostics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
3.223.696.4712.9717.95
Cash & Short-Term Investments
3.223.696.4712.9717.95
Cash Growth
-12.70%-43.00%-50.10%-27.75%-33.79%
Accounts Receivable
0.621.230.680.921.86
Other Receivables
1.080.831.141.762.63
Receivables
1.692.061.822.684.49
Inventory
1.651.842.143.423.04
Total Current Assets
6.567.5910.4319.0725.48
Property, Plant & Equipment
1.071.722.743.983.73
Other Intangible Assets
1.031.191.361.371
Long-Term Deferred Charges
0.620.881.942.22.03
Total Assets
9.2811.3816.4726.6232.24
Accounts Payable
0.380.480.180.380.65
Accrued Expenses
0.440.50.890.921.1
Current Portion of Leases
0.160.080.170.160.07
Current Unearned Revenue
1.120.050.19--
Other Current Liabilities
0.060.080.070.080.3
Total Current Liabilities
2.171.191.491.532.13
Long-Term Leases
0.03-0.080.18-
Other Long-Term Liabilities
0.110.110.10.090.02
Total Liabilities
2.31.291.681.812.15
Common Stock
71.8470.0968.0468.0467.92
Retained Earnings
-64.95-60.09-53.55-44.03-38.32
Comprehensive Income & Other
0.090.090.30.80.49
Shareholders' Equity
6.9810.0814.7924.8130.09
Total Liabilities & Equity
9.2811.3816.4726.6232.24
Total Debt
0.190.080.250.340.07
Net Cash (Debt)
3.033.66.2212.6317.88
Net Cash Growth
-15.78%-42.03%-50.77%-29.38%-33.90%
Net Cash Per Share
0.000.010.010.020.03
Filing Date Shares Outstanding
810.18639.2570.89570.89568.6
Total Common Shares Outstanding
739.12639.2570.89570.89568.6
Working Capital
4.46.48.9417.5323.35
Book Value Per Share
0.010.020.030.040.05
Tangible Book Value
5.958.8913.4323.4429.09
Tangible Book Value Per Share
0.010.010.020.040.05
Machinery
7.177.147.137.076.14
Leasehold Improvements
0.480.470.470.46-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.